P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance

被引:158
|
作者
Lespine, Anne [1 ]
Menez, Cecile [1 ]
Bourguinat, Catherine [2 ]
Prichard, Roger K. [2 ]
机构
[1] Univ Toulouse, INP, TOXALIM, INRA UMR1331, F-31027 Toulouse, France
[2] McGill Univ, Inst Parasitol, Montreal, PQ, Canada
来源
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE | 2012年 / 2卷
基金
加拿大自然科学与工程研究理事会;
关键词
Multidrug ABC transporters; P-glycoproteins; Anthelmintic resistance; Macrocyclic lactones; NEMATODE HAEMONCHUS-CONTORTUS; HIGH-AFFINITY BINDING; BLOOD-BRAIN-BARRIER; IN-VITRO; ONCHOCERCA-VOLVULUS; BETA-TUBULIN; ABC-TRANSPORTER; BENZIMIDAZOLE RESISTANCE; IVERMECTIN RESISTANCE; MACROCYCLIC LACTONE;
D O I
10.1016/j.ijpddr.2011.10.001
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Parasitic helminths cause significant disease in animals and humans. In the absence of alternative treatments, anthelmintics remain the principal agents for their control. Resistance extends to the most important class of anthelmintics, the macrocyclic lactone endectocides (MLs), such as ivermectin, and presents serious problems for the livestock industries and threatens to severely limit current parasite control strategies in humans. Understanding drug resistance is important for optimizing and monitoring control, and reducing further selection for resistance. Multidrug resistance (MDR) ABC transporters have been implicated in ML resistance and contribute to resistance to a number of other anthelmintics. MDR transporters, such as P-glycoproteins, are essential for many cellular processes that require the transport of substrates across cell membranes. Being overexpressed in response to chemotherapy in tumour cells and to ML-based treatment in nematodes, they lead to therapy failure by decreasing drug concentration at the target. Several anthelmintics are inhibitors of these efflux pumps and appropriate combinations can result in higher treatment efficacy against parasites and reversal of resistance. However, this needs to be balanced against possible increased toxicity to the host, or the components of the combination selecting on the same genes involved in the resistance. Increased efficacy could result from modifying anthelmintic pharmacokinetics in the host or by blocking parasite transporters involved in resistance. Combination of anthelmintics can be beneficial for delaying selection for resistance. However, it should be based on knowledge of resistance mechanisms and not simply on mode of action classes, and is best started before resistance has been selected to any member of the combination. Increasing knowledge of the MDR transporters involved in anthelmintic resistance in helminths will play an important role in allowing for the identification of markers to monitor the spread of resistance and to evaluate new tools and management practices aimed at delaying its spread. (C) 2011 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:58 / 75
页数:18
相关论文
共 27 条
  • [1] P-glycoproteins and multidrug resistance
    Bellamy, WT
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 : 161 - 183
  • [2] Multidrug resistance in parasites: ABC transporters, P-glycoproteins and molecular modelling
    Jones, PM
    George, AM
    INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2005, 35 (05) : 555 - 566
  • [3] P-glycoproteins in anthelmintic safety, efficacy, and resistance
    Lespine, Anne
    Blancfuney, Clara
    Prichard, Roger
    Alberich, Melanie
    TRENDS IN PARASITOLOGY, 2024, 40 (10) : 896 - 913
  • [4] Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis
    Metherall, JE
    Li, HJ
    Waugh, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (05) : 2634 - 2640
  • [5] MULTIDRUG-RESISTANCE AND P-GLYCOPROTEINS IN PARASITIC PROTOZOA
    ULLMAN, B
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1995, 27 (01) : 77 - 84
  • [6] Role of multidrug resistance P-glycoproteins in cholesterol esterification
    Debry, P
    Nash, EA
    Neklason, DW
    Metherall, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1026 - 1031
  • [7] P-GLYCOPROTEINS IN PATHOLOGY - THE MULTIDRUG RESISTANCE GENE FAMILY IN HUMANS
    WEINSTEIN, RS
    KUSZAK, JR
    KLUSKENS, LF
    COON, JS
    HUMAN PATHOLOGY, 1990, 21 (01) : 34 - 48
  • [8] Expression of multidrug resistance p-glycoproteins (MDR), multidrug resistance-associated proteins (MRP) and bile acid transporters in human hepatocellular carcinomas (HCC).
    Zollner, G
    Fickert, P
    Silbert, D
    Fuchsbichler, A
    Stumptner, C
    Ott, P
    Zatloukal, K
    Denk, H
    Trauner, M
    HEPATOLOGY, 2001, 34 (04) : 665A - 665A
  • [9] Strategies for inhibition of P-glycoproteins for effective treatment of multidrug resistance tumors
    Murthy, R. S. R.
    Shah, Neha M.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2007, 3 (01) : 1 - 17
  • [10] Expression of multidrug resistance P-glycoproteins (MDRs) and multidrug resistance-associated proteins (MRPs) in Wilson disease (WD)
    Zollner, G
    Fickert, P
    Fuchsbichler, A
    Stumptner, C
    Denk, H
    Zatloukal, K
    Ferenci, P
    Trauner, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 188 - 188